文献速递慢性静脉疾病

静脉内激光消融伴与不伴血栓预防后的静脉血栓形成

Venous thrombosis following endovenous laser ablation with and without thromboprophylaxis.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2023-08-07

该研究回顾性分析前瞻性VEINOVA登记中2019年10月至2020年3月连续223例接受静脉内激光消融(EVLA)的患者,比较术后给予与未给予药物性血栓预防的静脉血栓栓塞(VTE)发生率。结果显示两组血栓事件率均低,伴与不伴药物性血栓预防的EVLA似乎安全,但需更多数据才能给出最佳血栓预防方案的最终推荐。

要点

  • 223例患者中132例(59.2%)术后接受3天药物性血栓预防,91例(40.8%)未接受。
  • 随访1周时两组均无血栓事件;随访4周时未预防组发生1例EHIT 2级(1.1%)和1例肺栓塞(1.1%),预防组发生1例深静脉血栓(0.8%),校正P=0.135。
  • 随访1周和4周时两组治疗静脉均保持闭塞。

核心结论

  • 主干静脉曲张的静脉内消融伴或不伴药物性血栓预防似乎安全,血栓事件率低。
  • 在给出最佳血栓预防治疗方案的最终推荐之前,需要更多数据。

研究设计与样本

  • 回顾性分析2019年10月至2020年3月前瞻性维护的VEINOVA(vein occlusion with various techniques)登记中连续患者。
  • 最终纳入223例连续患者、223条腿和227条大隐静脉(159条大隐静脉、49条小隐静脉和19条前副大隐静脉)。
  • 患者平均年龄58.1±13.8岁,167例(73.1%)为女性。
  • CEAP分类:C2 11条腿(4.9%),C3 123条腿(55.2%),C4a或C4b 86条腿(38.6%),C5至C6 3条腿(1.4%)。
  • 132例(59.2%)接受3天血栓预防(利伐沙班10 mg每日一次130例[98.5%],低分子肝素2例[1.5%]),91例(40.8%)未接受血栓预防。

主要发现

  • 平均治疗长度34.2±19.3 cm,平均直径5.0±1.3 mm。
  • 随访1周时两组均无血栓事件发生。
  • 随访4周时未预防组发生1例EHIT 2级(1.1%)和1例肺栓塞(1.1%)。
  • 随访4周时预防组发生1例深静脉血栓(0.8%)(校正P=0.135)。
  • 随访1周和4周时两组治疗静脉均保持闭塞。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Venous thromboembolism (VTE) occurs infrequently after endovenous laser ablation (EVLA). The purpose of this study was to assess the incidence of VTE after EVLA with and without pharmacologic prophylaxis. METHODS: From October 2019 to March 2020, a series of consecutive patients from the prospectively maintained VEINOVA (vein occlusion with various techniques) registry was retrospectively analyzed. All the patients underwent EVLA with and without postoperative thromboprophylaxis. A 1470-nm laser wavelength with a radial fiber was used for EVLA. Concomitant phlebectomy or sclerotherapy of insufficient tributaries was allowed. Perivenous tumescence was applied with 1% Rapidocaine (lidocaine hydrochloride monohydrate; Sintetica SA). Ablation of varicose veins was performed by continuously drawing back the laser fiber at a power of 10 W, aiming for a linear endovenous energy delivery of 60 to 90 J/cm. Compression stockings were applied postoperatively, and the patients were advised to wear them for 1 week. Duplex ultrasound was performed at the 1- and 4-week follow-up visits to determine the occlusion rate and the occurrence of EHIT and VTE. RESULTS: Overall, 249 patients were identified from the registry. Of the 249 patients, 26 were omitted because of treatment of recurrent varicose veins. Finally, 223 consecutive patients with 223 legs and 227 saphenous veins (159 great saphenous veins, 49 small saphenous veins, and 19 anterior accessory saphenous veins) were included in the final analysis. Their mean age was 58.1 ± 13.8 years, and 167 patients (73.1%) were women. The clinical CEAP (clinical, etiology, anatomy, pathophysiology) classification was C2 for 11 legs (4.9%), C3 for 123 legs (55.2%), C4a or C4b for 86 legs (38.6%), and C5 to C6 for 3 legs (1.4%). Thromboprophylaxis was given to 132 patients (59.2%) for 3 days (rivaroxaban 10 mg once daily to 130 patients [98.5%] and low-molecular-weight heparin to 2 patients [1.5%]). No thromboprophylaxis was administered to 91 patients (40.8%) after EVLA. The average treatment length was 34.2 ± 19.3 cm and the average diameter was 5.0 ± 1.3 mm. At 1 week of follow-up, no thrombotic event had occurred in either group. At 4 weeks of follow-up, one case of EHIT class 2 (1.1%) and one case of pulmonary embolism (1.1%) had occurred in the group without thromboprophylaxis. In the thromboprophylaxis group, one deep vein thrombosis (0.8%) event had occurred (adjusted P = .135). At 1 and 4 weeks of follow-up, the treated varicose veins remained occluded in both groups. CONCLUSIONS: Endovenous ablation of truncal varicose veins appears to be safe with a low thrombotic event rate with or without pharmacologic thromboprophylaxis. However, more data are needed before a final recommendation regarding the best thromboprophylaxis treatment option can be given.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Keo HH, Knoechel J, Diehm N, et al. Venous thrombosis following endovenous laser ablation with and without thromboprophylaxis. J Vasc Surg Venous Lymphat Disord. 2023. PMID: 37557982. doi:10.1016/j.jvsv.2022.08.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。